T1	Concept 7 19	analysis 197
T2	Concept 23 39	membrane protein
T3	Concept 94 108	SARS-CoV-2 198
T4	Concept 122 135	other viruses
T5	Concept 71 78;79 84;85 90	similar codon usage
T6	Concept 41 59	pangolin P1E virus
T7	Action 60 63	had
T8	Concept 140 159	virtual elimination
T9	Concept 163 172	HCoV-OC43
T10	Concept 177 186	HCoV-HKU1
T11	Action 187 204	would be possible
T12	Concept 208 218	SARS-CoV-2
T14	Action 219 226	induced
A1	Emphasized T5
T13	Concept 227 245	70% cross immunity
T15	Concept 288 311	level of cross-immunity
A2	Uncertain T15
T16	Concept 317 326	HCoV-OC43
T17	Concept 343 352	HCoV-HKU1
T18	Concept 360 367	results
T19	Action 368 375	confirm
T20	Concept 381 391	SARS-CoV-2
T21	Concept 401 437	canonical TRS-mediated 144 mechanism
T23	Concept 442 469	discontinuous transcription
T24	Action 473 480	produce
T25	Concept 487 493	sgRNAs
A3	Emphasized T25
T26	Concept 494 505	Lung injury
T27	Action 506 512	begins
T28	Concept 521 527	insult
T29	Concept 535 550	lung epithelium
R2	has-property Arg1:T6 Arg2:T5	
R3	subject Arg1:T7 Arg2:T6	
R4	target Arg1:T7 Arg2:T5	
R6	has-part Arg1:T8 Arg2:T9	
R7	subject Arg1:T14 Arg2:T12	
T30	Concept 254 258	them
R8	has-property Arg1:T12 Arg2:T13	
*	same-as T13 T15
R13	has-property Arg1:T20 Arg2:T21	
R15	subject Arg1:T24 Arg2:T20	
R16	target Arg1:T24 Arg2:T25	
R17	entails Arg1:T13 Arg2:T8	
R18	target Arg1:T11 Arg2:T8	
R19	is-a Arg1:T11 Arg2:T13	
R20	target Arg1:T14 Arg2:T13	
R9	has-part Arg1:T8 Arg2:T10	
T22	Action 327 334	induces
R10	subject Arg1:T16 Arg2:T22	
R21	target Arg1:T22 Arg2:T17	
R22	target Arg1:T19 Arg2:T20	
T31	Action 392 396	uses
R23	subject Arg1:T31 Arg2:T20	
R24	target Arg1:T31 Arg2:T21	
R25	subject Arg1:T27 Arg2:T26	
R26	target Arg1:T27 Arg2:T28	
R27	has-part Arg1:T28 Arg2:T29	
T32	Action 558 566	attacked
A4	Emphasized T32
R28	subject Arg1:T32 Arg2:T29	
T33	Concept 570 580	SARS-CoV-2
T34	Concept 581 587	itself
*	same-as T34 T33
R29	target Arg1:T32 Arg2:T33	
T35	Concept 599 603	ACE2
T36	Action 604 613	expressed
T37	Concept 621 626	lungs
R30	subject Arg1:T36 Arg2:T35	
R31	target Arg1:T36 Arg2:T37	
R32	entails Arg1:T36 Arg2:T32	
T38	Action 634 639	leads
T39	Concept 655 674	respiratory failure
R33	target Arg1:T38 Arg2:T39	
R34	subject Arg1:T38 Arg2:T36	
T40	Concept 684 697	global spread
T41	Concept 701 711	SARS-CoV-2
R35	has-property Arg1:T41 Arg2:T40	
T42	Concept 717 736	amino acid sequence
T43	Action 759 765	varied
A5	Emphasized T43
R36	target Arg1:T43 Arg2:T42	
R37	subject Arg1:T43 Arg2:T40	
R38	in-context Arg1:T1 Arg2:T6	
R1	has-property Arg1:T6 Arg2:T2	
R39	in-context Arg1:T1 Arg2:T2	
R40	in-context Arg1:T5 Arg2:T4	
R5	has-part Arg1:T5 Arg2:T3	
R41	subject Arg1:T11 Arg2:T14	
R42	in-place Arg1:T9 Arg2:T30	
R43	in-place Arg1:T10 Arg2:T30	
R11	in-context Arg1:T15 Arg2:T16	
R12	subject Arg1:T19 Arg2:T18	
R14	has-part Arg1:T21 Arg2:T23	
